Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:

October 1, 2009
Dr. John Nash has been named senior director of ADME/PK for BioFocus.  Read More »

September 30, 2009
Hospira, Inc. has acquired worldwide rights to a biogeneric version of filgrastim and an affiliated manufacturing facility from PLIVA Hrvatska in Zagreb, Croatia.  Read More »

September 30, 2009
Almac has plans for a major expansion at its Craigavon headquarters and has acquired a 5.4-acre site for the first phase of development.  Read More »

September 30, 2009
Covance, Inc. has added cGMP melamine testing services in North America to meet recent FDA guidance on melamine testing for pharmaceutical and animal health manufacturers.  Read More »

September 30, 2009
Will Downie has been appointed group president, Sterile Technologies and senior vice president of Global Sales and Marketing, Catalent Pharma Solutions, effective October 12, 2009.  Read More »

September 29, 2009
Catalent Pharma Solutions and GlaxoSmithKline (GSK) have extended their contract under which Catalent will continue to supply GSK with its trade requirements of Lovaza omega-3 acid ethyl esters in soft gelatin capsules.  Read More »

September 29, 2009
Patheon has opened a new Pharmaceutical Development Services (PDS) manufacturing site for investigational medical products within its existing manufacturing facility in Ferentino, Italy.  Read More »

September 29, 2009
Laureate Pharma has entered into a development and manufacturing agreement with ZZ Biotech, LLC, under which Laureate will produce Activated Protein C variant under cGMP conditions.  Read More »

September 29, 2009
West Pharmaceutical Services, Inc. has opened its new 129,000-sq.-ft. injection-molding factory in the Shanghai Qingpu Industrial Zone (SQIZ) in China.  Read More »

September 29, 2009
Vetter recently inaugurated its Ravensburg South site with a new 862,000 sq.-ft. area that now includes facilities for the aseptic filling and packaging of injectable drugs.  Read More »

September 28, 2009
Abbott has entered a definitive agreement with the Solvay Group to acquire Solvay's pharmaceuticals business for $6.6 billion in cash.  Read More »

September 28, 2009
Johnson & Johnson, through its subsidiary Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Crucell have entered into a strategic collaboration for the discovery, development and commercialization of monoclonal antibodies and vaccines for the treatment and   Read More »

September 23, 2009
Opexa achieved its first milestone in its stem cell pact with Novartis.  Read More »

September 23, 2009
Azopharma will perform research services to further develop ImmuneRegen's lead drug candidate Homspera  Read More »

September 22, 2009
Pfizer and Wyeth have entered into an agreement with Boehringer Ingelheim to divest certain animal health assets, pending Pfizer’s acquisition of Wyeth.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On